bDepartment of Biostatistics and Epidemiology, University Hospital of Saint-Louis, Paris, France cDepartment of Hematology, University Hospital of Saint-Louis, Paris, France dDepartment of Hematology, ...
Methods: In this 6-month, 2-arm, multicenter, unblinded randomized controlled trial, patients aged 18 years or older diagnosed with T2DM were randomly assigned (1:1) to an intervention group (IG) ...
Sagimet Biosciences dropped 9% after Ascletis Pharma’s Phase 3 Denifanstat safety data focused on tolerability, not new efficacy, spurring investor caution. SGMT’s Denifanstat, a first-in-class FASN ...
aDeakin University, IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Victoria, Australia bDepartment of Public Health, College of Health ...
Background and aims: Accumulating evidence has demonstrated the benefits of soy and its extracts on glycemic control and insulin sensitivity. We hypothesized that different soy components might ...
A randomized, double-blind, three-arm, parallel group, phase 1 study to assess the pharmacokinetics, safety, and tolerability of PERT-IJS following a single dose of 420 mg intravenous infusion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results